Basic science research discoveries are foundational to improving cardiovascular health and curing heart disease. The Duke Cardiovascular Research Center is a world leader in basic cardiovascular research. Our work is led by prominent scientists, many of whom are also dedicated physicians, working to improve patient care through new discoveries.
Working Toward the Future
Research remains foundational to addressing impending challenges in cardiovascular disease. The basic and translational scientists in the Duke Cardiovascular Research Center have a mission of service to guide Duke Heart toward the future, by promoting creative integration across the basic, translational and clinical enterprise to accomplish key initiatives in discovery science, innovation, preventive cardiology, and cardiovascular disease treatment.
The Duke Cardiovascular Research Center is now ramping up to strengthen this continuum of cardiology research, which culminates in improved patient care. The CVRC also has a mission of scholarship, training, and mentoring to develop the next generation leaders. To accomplish these goals, the Cardiovascular Research Center is eager to partner at all levels—with caregivers, other institutions, industry, and innovative thinkers willing to contribute to this cause and answer the call to action.
Together, we can make an investment in a future with better tools and medicines for the prevention and treatment of cardiovascular disease.
The chemistry of discovery
Duke CVRC's Nobel Laureate, Robert Lefkowitz, MD, on how science develops from asking big questions and accepting inevitable failure.
The Victor J. Dzau Lecture Series in Cardiovascular Research supported by the Mandel Foundation
The Victor J. Dzau Seminar Series features presentations on cardiovascular topics by visiting researchers and Duke faculty.
Kelly A. Frazer, PhD (right) Professor, Pediatrics and Institute for Genomic Medicine of UC San Diego will be the presenter on May 18, 2022.
Nour Nazo, lab manager of the Rajagopal Lab in the Duke Cardiovascular Research Center (CVRC), has been named the 2020 recipient of the CVRC Research Staff Appreciation Award.
Jessica Regan, MD, has been selected as the Duke Cardiovascular Research Center's 2020 Mandel Fellow.
The Duke Cardiovascular Research Center announced that three projects led by CVRC faculty have received Mandel Seed Awards.
Dennis Abraham, MD, and Brent Hanks, MD, PhD, have been selected to receive 2019 Physician-Scientist Strong Start Awards.
The Duke Cardiovascular Research Center (CVRC) has announced the recipients of the CVRC Mandel Travel Award for the upcoming Stanford-Duke Cardiovascular Research Symposium in Palo Alto, California.
The inaugural Duke Cardiovascular Research Center (CVRC) Research Staff Appreciation Award was presented to William Darrell Capel earlier this week. Capel was nominated by his direct supervisor, Robert Lefkowitz, MD, and was recognized for his service as a mentor and teacher in the lab.
The Duke Cardiovascular Research Center is launching an Executive Seminar Series that will provide the latest thinking in cardiovascular research and clinical care.
Since 1990, the Rockman Lab has utilized the power of teamwork, positivity, and creative thinking in their investigation of the molecular mechanisms of hypertrophy and heart failure.
Robert J. Lefkowitz, MD, will present his research at the Department's Research Seminar Series at noon on Friday, Jan. 27, 2017 in Duke Hospital Room 2002. Dr. Lefkowitz will discuss G-Protein Coupled Receptors.
Four faculty in the Division of Cardiology have received awards from the Mandel Center for Hypertension and Atherosclerosis at Duke. The faculty are members of the Duke Cardiovascular Research Center, which has a mission of scholarship, training, and mentoring that includes developing the next leaders in cardiovascular discovery research.